Overview


According to FutureWise analysis the market for otc consumer healthcare in 2023 is US$ 204.49 million, and is expected to reach US$ 282.45 million by 2031 at a CAGR of 4.10%.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Otc Consumer Healthcare Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Otc Consumer Healthcare Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Sun Pharmaceutical Industries Limited
  • Glenmark Pharmaceuticals Ltd.
  • Johnson & Johnson Private Ltd.
  • Pfizer, Inc.
  • American Health Corporation
  • Abbott Laboratories Inc.
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Piramal Enterprises Ltd.
  • Boehringer Ingelheim GmbH
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • Ipsen SA
  • BASF SE
  • Koninklijke DSM N.V.
  • Reckitt Benckiser LLC
  • Lonza Group Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends

By Product

  • OTC Pharmaceuticals
    • Eye Care
    • Oral Health Care
    • Medicated Skin Care
    • Wound Care
    • Digestive Remedies
    • Sleeping Aids
    • Emergency Contraceptives
    • Intimate Care
    • Hair Care
    • Cough, Cold & Allergy Remedies
    • Analgesics
    • Dermatological
  • Dietary Supplements
    • Nutrition
    • Vitamins
    • Minerals
    • Proteins
    • Others

By Sales Channel

  • Wholesalers & Distributors
  • Pharmacy or Drug Stores
  • Specialty Stores
  • Online Retailers
  • Hypermarkets/Supermarkets
  • Other Sales Channels

By Form

  • Tablet
  • Powder
  • Liquid
  • Others

By End User

  • Male
  • Female
  • Kids

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Otc Consumer Healthcare Market By Product, By Sales Channel, By Form, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations14
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Otc Consumer Healthcare Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Otc Consumer Healthcare Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Otc Consumer Healthcare Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Otc Consumer Healthcare Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. OTC Pharmaceuticals
         1.1. Eye Care
         1.2. Oral Health Care
         1.3. Medicated Skin Care
         1.4. Wound Care
         1.5. Digestive Remedies
         1.6. Sleeping Aids
         1.7. Emergency Contraceptives
         1.8. Intimate Care
         1.9. Hair Care
         1.10.Cough, Cold & Allergy Remedies
         1.11.Analgesics
         1.12.Dermatological
        2. Dietary Supplements
         2.1. Nutrition
         2.2. Vitamins
         2.3. Minerals
         2.4. Proteins
         2.5. Others

  • 8.   Global Otc Consumer Healthcare Market, By Sales Channel Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Wholesalers & Distributors
        2. Pharmacy or Drug Stores
        3. Specialty Stores
        4. Online Retailers
        5. Hypermarkets/Supermarkets
        6. Other Sales Channels

  • 9.   Global Otc Consumer Healthcare Market, By Form Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Tablet
        2. Powder
        3. Liquid
        4. Others

  • 10.   Global Otc Consumer Healthcare Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Male
        2. Female
        3. Kids

  • 11.   North America Otc Consumer Healthcare Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Otc Consumer Healthcare Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Otc Consumer Healthcare Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Otc Consumer Healthcare Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •     1. Sun Pharmaceutical Industries Limited
                  1.1. Company Overview
                  1.2. Product Portfolio
                  1.3. SWOT Analysis
                  1.4. Financial Overview
                  1.5. Strategic Overview
          2. Glenmark Pharmaceuticals Ltd.
                  2.1. Company Overview
                  2.2. Product Portfolio
                  2.3. SWOT Analysis
                  2.4. Financial Overview
                  2.5. Strategic Overview
          3. Johnson & Johnson Private Ltd.
                  3.1. Company Overview
                  3.2. Product Portfolio
                  3.3. SWOT Analysis
                  3.4. Financial Overview
                  3.5. Strategic Overview
          4. Pfizer, Inc.
                  4.1. Company Overview
                  4.2. Product Portfolio
                  4.3. SWOT Analysis
                  4.4. Financial Overview
                  4.5. Strategic Overview
          5. American Health Corporation
                  5.1. Company Overview
                  5.2. Product Portfolio
                  5.3. SWOT Analysis
                  5.4. Financial Overview
                  5.5. Strategic Overview
          6. Abbott Laboratories Inc.
                  6.1. Company Overview
                  6.2. Product Portfolio
                  6.3. SWOT Analysis
                  6.4. Financial Overview
                  6.5. Strategic Overview
          7. GlaxoSmithKline plc
                  7.1. Company Overview
                  7.2. Product Portfolio
                  7.3. SWOT Analysis
                  7.4. Financial Overview
                  7.5. Strategic Overview
          8. Sanofi S.A.
                  8.1. Company Overview
                  8.2. Product Portfolio
                  8.3. SWOT Analysis
                  8.4. Financial Overview
                  8.5. Strategic Overview
          9. Piramal Enterprises Ltd.
                  9.1. Company Overview
                  9.2. Product Portfolio
                  9.3. SWOT Analysis
                  9.4. Financial Overview
                  9.5. Strategic Overview
          10. Boehringer Ingelheim GmbH
                  10.1. Company Overview
                  10.2. Product Portfolio
                  10.3. SWOT Analysis
                  10.4. Financial Overview
                  10.5. Strategic Overview
          11. Bayer AG
                  11.1. Company Overview
                  11.2. Product Portfolio
                  11.3. SWOT Analysis
                  11.4. Financial Overview
                  11.5. Strategic Overview
          12. Teva Pharmaceutical Industries Ltd.
                  12.1. Company Overview
                  12.2. Product Portfolio
                  12.3. SWOT Analysis
                  12.4. Financial Overview
                  12.5. Strategic Overview
          13. Ipsen SA
                  13.1. Company Overview
                  13.2. Product Portfolio
                  13.3. SWOT Analysis
                  13.4. Financial Overview
                  13.5. Strategic Overview
          14. BASF SE
                  14.1. Company Overview
                  14.2. Product Portfolio
                  14.3. SWOT Analysis
                  14.4. Financial Overview
                  14.5. Strategic Overview
          15. Koninklijke DSM N.V.
                  15.1. Company Overview
                  15.2. Product Portfolio
                  15.3. SWOT Analysis
                  15.4. Financial Overview
                  15.5. Strategic Overview
          16. Reckitt Benckiser LLC
                  16.1. Company Overview
                  16.2. Product Portfolio
                  16.3. SWOT Analysis
                  16.4. Financial Overview
                  16.5. Strategic Overview
          17. Lonza Group Ltd.
                  17.1. Company Overview
                  17.2. Product Portfolio
                  17.3. SWOT Analysis
                  17.4. Financial Overview
                  17.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated
      by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11